Delphi Private Advisors’s AbbVie ABBV Stock Holding History

Delphi Private Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-800	Closed	-$77K	–	79
2017 Q4	$77K	Buy	+800	New	+$75.4K	0.19%	51
2017 Q3	–	Sell	-1,274	Closed	-$92K	–	81
2017 Q2	$92K	Hold	1,274	–	–	0.18%	25
2017 Q1	$83K	Sell	1,274 -513	-29%	-$32.3K	0.15%	24
2016 Q4	$112K	Buy	1,787 +1,642	+1,132%	+$100K	0.2%	26
2016 Q3	$9K	Sell	145 -162	-53%	-$10.5K	0.02%	118
2016 Q2	$19K	Buy	307 +32	+12%	+$1.95K	0.03%	93
2016 Q1	$16K	Sell	275 -96	-26%	-$5.35K	0.03%	110
2015 Q4	$22K	Buy	+371	New	+$21.4K	0.04%	99

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Delphi Private Advisors's ABBV Position: Q1 2018 in Review

Delphi Private Advisors sold out of AbbVie (ABBV) in Q1 2018, closing a stake of 800 shares — an estimated $77K sold.

Delphi Private Advisors first reported a position in ABBV in Q4 2015 and held it in 8 quarters. The position peaked at $112K in Q4 2016. 2,015 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

Delphi Private Advisors reported no remaining AbbVie position as of Q1 2018 after selling out during the quarter.
Delphi Private Advisors sold 800 AbbVie shares in Q1 2018, an estimated $77K.
Delphi Private Advisors first reported a position in AbbVie in Q4 2015 and held it in 8 quarters.
Delphi Private Advisors's AbbVie position peaked at $112K in Q4 2016.
2,015 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Delphi Private Advisors's 13F filing for Q1 2018, filed 2 May 2018.